期刊文献+

糖尿病性黄斑水肿的治疗进展

Review on the progress of the treatment of diabetic macular edema
下载PDF
导出
摘要 糖尿病性黄斑水肿(diabetic macular edema,DME)是导致糖尿病视网膜病变患者视力下降的主要原因之一,作者对近年来糖尿病性黄斑水肿的定义、分类、发病机制以及不同药物治疗等有关报道进行了综述。随着对各种药物不断深入地研究,糖尿病性黄斑水肿可得到及时治疗。使糖尿病患者的视力受到保护。 Diabetic macular edema is the primary Cause for the vision loss of patients with diabetes. People have made a lot of relative clinical studies. In this paper, the author reviews the definition, classification, pathogenesis and the treatment of different drugs in recent years. With the progress was made in clinical research of different drugs, diabetic maeular edema call be treated in time. Thereby the eyesight of Diabetic patients with diabetes call be protected.
作者 朱子诚
出处 《实用防盲技术》 2012年第3期134-138,共5页 Journal of Practical Preventing Blind
关键词 糖尿病 黄斑水肿 发病机制 药物治疗 Diabetes Macularedema Pathogenesy Drug treatment
  • 相关文献

参考文献22

  • 1Beck RW, Edwards AR, Aiello LP, et al. Three-year follow- up of a randomized trial comparing focal/grid photocoagulation and intravitreal triamcinolone for diabetic macularedema. Arch Ophthalmol, 2009; 127: 245-51.
  • 2Fong DS, Strauber SF, Aiello LP,et al. Comparison of Modified-ETDRS and Mild Macular Grid Laser Photocoagulation Strategies for Diabetic Macular Edema. Arch Ophthalmol, 2007, 125: 469-80.
  • 3Luttrull JK, Musch DC,et al .Subthreshold diode micropulse photocoagulation for the treatment of clinically significant diabetic macular edema. Br J Ophthalmol, 2005 Jan, 89: 74-80.
  • 4Wilson AS, Hobbs BG, Shen WY, et al. Argon laser photoeoagulation-indueed modification of gene expression in the retina. Invest Ophthalmol Vis Sci, 2003, 44: 1426- 1434.
  • 5Roider J, Brinkmann R, Wirt3dauer C, et al. Subthreshold (retinal pigment epithelium)ph0tocoagulation in macular diseases: a pilot study. Br J Ophthalmol, 2000, 84: 40- 47.
  • 6Laursen ML, Moeller F, Sander B, Sjoelie AK. Subthreshold micropulse diode laser treatment in diabetic macular oedema. Br J Ophthalmol, 2004, 88:1173-9.
  • 7Gallego-Pinazo R, Suelves-Cogollos AM, Dolz-Marco R, et al. Macular laser photocoagulation guided by spectral- domain optical coherence tomography versus fluorescein angiography for diabetic macular edema. Clin Ophthalmol. 2011, 5: 613-617.
  • 8PKC-DRS2 Group. Elect of ruboxistaurin on Visual Loss in patients with Diabetic Retinaopathy. OphthaLmology, 2006, 113: 2048-2053.
  • 9Yoshimura T, Sonoda KH, Sugahara M,et a 1. Comprehensive analysis of inflammatory immune mediators in vitreoretinal diseases. PLoS One, 2009, Dee 4, 4:e8158.
  • 10Marey HM, Ellakwa AF. Intravitreal bevacizumab alone or combined with triamcinolone acetonide as the primary treatment for diabetic macular edema. Clin Ophthalmol. 2011, 5: 1011-6.

二级参考文献27

共引文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部